Drug Shortage Report for SANDOZ MYCOPHENOLATE MOFETIL
Report ID | 93403 |
Drug Identification Number | 02313855 |
Brand name | SANDOZ MYCOPHENOLATE MOFETIL |
Common or Proper name | MYCOPHENOLAT MOFE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-08-19 |
Estimated end date | 2020-08-07 |
Actual end date | 2020-08-03 |
Shortage status | Resolved |
Updated date | 2020-08-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.